CORONA Remedies Announces 22nd AGM on July 9, 2026; July 2 Cut-off Date
CORONA Remedies Limited will hold its 22nd Annual General Meeting on July 9, 2026, via video conference. July 2, 2026, is the cut-off date for voting eligibility. The company reported FY26 revenue of ₹1,403.18 Crores, Operating Profit of ₹293.44 Crores, and PAT of ₹199.42 Crores.
The announcement pertains to a scheduled AGM and reporting of past financial performance, which is standard corporate practice and does not introduce significant new information that would impact the company's valuation or operations.
The announcement is a routine corporate event (AGM notice) and financial highlights, which are neutral in nature.
CORONA Remedies Limited has announced that its 22nd Annual General Meeting (AGM) will be held on Thursday, July 09, 2026, at 11:00 a.m. The meeting will be conducted through Video Conferencing (VC) / Other Audio Visual Means (OAVM), in compliance with circulars from the Ministry of Corporate Affairs and SEBI.
The company has also fixed Thursday, July 02, 2026, as the cut-off date for determining which members are eligible to vote electronically and attend the AGM. The Annual Report for the Financial Year 2025-26, which includes the Notice of AGM, has been submitted and will be sent to members via electronic mode. It will also be available on the company's website, www.coronaremedies.com.
The company reported significant financial highlights for FY 2025-26, including Revenue from Operations of ₹1,403.18 Crores, Operating Profit of ₹293.44 Crores, and PAT of ₹199.42 Crores. The India business achieved a revenue growth of 17.18%, outperforming the IPM growth of 8.59%. The company also highlighted strategic achievements such as brand acquisitions and capacity expansion.
What to do with a filing like this
CORONA Remedies Limited filed this with the NSE as a statutory disclosure, categorised under agm. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by CORONA Remedies Limited. Read the original for the full detail.